Abstract:Highlights • FGF21 expression in hepatocytes and macrophages is upregulated during sepsis. • FGF21 inhibits proinflammatory macrophage activation by resuming autophagy flux to ameliorate septic liver injury. • FGF21 accelerates autolysosome degradation via mTOR signaling, while it has no effect on autophagosome formation induced by LPS via ERK and JNK signaling pathways. • FGF21 promotes p62-dependent autophagic degradation of HIF-1α in macrophages by enhancing the interaction between p62 and HIF-1α. Introduction Sepsis, a systemic immune syndrome caused by severe trauma or infection, poses a substantial threat to the health of patients worldwide. The progression of sepsis is heavily influenced by septic liver injury, which is triggered by infection and cytokine storms, and has a significant impact on the tolerance and prognosis of septic patients. The objective of our study is to elucidate the biological role and molecular mechanism of fibroblast growth factor 21 (FGF21) in the process of sepsis. Objectives This study was undertaken in an attempt to elucidate the function and molecular mechanism of FGF21 in therapy of sepsis. Methods Serum concentrations of FGF21 were measured in sepsis patients and septic mice. Liver injury was compared between mice FGF21 knockout (KO) mice and wildtype (WT) mice. To assess the therapeutic potential, recombinant human FGF21 was administered to septic mice. Furthermore, the molecular mechanism of FGF21 was investigated in mice with myeloid-cell specific HIF-1α overexpression mice (LyzM-Cre DIO-HIF-1α ) and myeloid-cell specific Atg7 knockout mice ( Atg7 △mye ). Results Serum level of FGF21 was significantly increased in sepsis patients and septic mice. Through the use of recombinant human FGF21 (rhFGF21) and FGF21 KO mice, we found that FGF21 mitigated septic liver injury by inhibiting the initiation and propagation of inflammation. Treatment with rhFGF21 effectively suppressed the activation of proinflammatory macrophages by promoting macroautophagy/autophagy degradation of hypoxia-inducible factor-1α (HIF-1α). Importantly, the therapeutic effect of rhFGF21 against septic liver injury was nullified in LyzM-Cre DIO-HIF-1α mice and Atg7 △mye mice. Conclusions Our findings demonstrate that FGF21 considerably suppresses inflammation upon septic liver injury through the autophagy/ HIF-1α axis. Graphical abstract Schematic showing that FGF21 alleviates septic liver injury by inhibiting proinflammatory activation of macrophages by promoting autophagic degradation of HIF-1α. Download : Download high-res image (242KB) Download : Download full-size image

FGF-21 Elevated IL-10 Production to Correct LPS-Induced Inflammation

Fibroblast Growth Factor 21 (FGF21) Inhibits Macrophage-Mediated Inflammation by Activating Nrf2 and Suppressing the NF-κB Signaling Pathway.

Fibroblast Growth Factor 21 Relieves Lipopolysaccharide-Induced Acute Lung Injury by Suppressing JAK2/STAT3 Signaling Pathway

FGF21 Attenuated LPS-Induced Depressive-Like Behavior via Inhibiting the Inflammatory Pathway

Fibroblast Growth Factor 21 Dependent TLR4/MYD88/NF-κB Signaling Activation is Involved in Lipopolysaccharide-Induced Acute Lung Injury.

Fibroblast growth factor 21 regulates foam cells formation and inflammatory response in Ox-LDL-induced THP-1 macrophages

A Novel Function for Fibroblast Growth Factor 21: Stimulation of NADPH Oxidase-Dependent ROS Generation

Fibroblast growth factor 21 (FGF21) ameliorates collagen-induced arthritis through modulating oxidative stress and suppressing nuclear factor-kappa B pathway

Fibroblast Growth Factor 21 Ameliorates Pancreatic Fibrogenesis Via Regulating Polarization of Macrophages.

[FGF21 inhibits lipid accumulation and inflammation induced by palmitate in human hepatocytes via SIRT1 pathway].

LFG-500, a newly synthesized flavonoid, attenuates lipopolysaccharide-induced acute lung injury and inflammation in mice.

Recombinant Murine Fibroblast Growth Factor 21 Ameliorates Obesity-Related Inflammation in Monosodium Glutamate-Induced Obesity Rats

Suppression of Cutibacterium acnes-Mediated Inflammatory Reactions by Fibroblast Growth Factor 21 in Skin

FGF21 attenuates pulmonary fibrogenesis through ameliorating oxidative stress in vivo and in vitro.

Fibroblast growth factor 21 mitigates lupus nephritis progression via the FGF21/Irgm 1/NLRP3 inflammasome pathway

FGF21 Depletion Attenuates Colitis through Intestinal Epithelial IL-22-STAT3 Activation in Mice

FGF21 Exerts Comparable Pharmacological Efficacy with Adalimumab in Ameliorating Collagen-Induced Rheumatoid Arthritis by Regulating Systematic Inflammatory Response.

FGF21 ameliorates septic liver injury by restraining proinflammatory macrophages activation through the autophagy/HIF-1α axis

Fibroblast Growth Factor 21 Exerts Its Anti‐inflammatory Effects on Multiple Cell Types of Adipose Tissue in Obesity

Improving Hyperglycemic Effect of FGF-21 is Associated with Alleviating Inflammatory State in Diabetes

Fibroblast Growth Factor 21 Suppresses Adipogenesis in Pig Intramuscular Fat Cells